September 8th, 2017
•Resistance to cancer therapies contributes to disease progression and death. Determining the mechanistic underpinnings of resistance is crucial for improving therapeutic response. This manuscript details the protocol to generate taxane-resistant cell models of prostate cancer (PC) to help dissecting the pathways involved in progression to Docetaxel resistance in PC patients.
Tags
Related Videos
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis
Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
Identification, Histological Characterization, and Dissection of Mouse Prostate Lobes for In Vitro 3D Spheroid Culture Models
Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells
Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved